AU2001223882A1 - Receptor - Google Patents

Receptor

Info

Publication number: AU2001223882A1
Authority: AU; Australia
Prior art keywords: receptor
Prior art date: 2000-01-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2001223882A

Inventor

Jameel Inal

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-01-10

Filing date

2001-01-10

Publication date

2001-07-24

2001-01-10 Application filed by Individual filed Critical Individual

2001-07-24 Publication of AU2001223882A1 publication Critical patent/AU2001223882A1/en

Status Abandoned legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
- C07K14/43559—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from trematodes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A61P33/12—Schistosomicides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies

AU2001223882A 2000-01-10 2001-01-10 Receptor Abandoned AU2001223882A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB0000474		2000-01-10
GBGB0000474.7A GB0000474D0 (en)	2000-01-10	2000-01-10	Receptor
PCT/GB2001/000085 WO2001051512A2 (en)	2000-01-10	2001-01-10	Human and parasite orphan receptor proteins

Publications (1)

Publication Number	Publication Date
AU2001223882A1 true AU2001223882A1 (en)	2001-07-24

Family

ID=9883439

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2001223882A Abandoned AU2001223882A1 (en)	2000-01-10	2001-01-10	Receptor

Country Status (10)

Country	Link
US (1)	US20030181362A1 (en)
EP (1)	EP1246840A2 (en)
JP (1)	JP2003519479A (en)
AU (1)	AU2001223882A1 (en)
BR (1)	BR0107547A (en)
CA (1)	CA2397053A1 (en)
GB (1)	GB0000474D0 (en)
MX (1)	MXPA02006817A (en)
WO (1)	WO2001051512A2 (en)
ZA (1)	ZA200205485B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6774209B1 (en)	2000-04-03	2004-08-10	Dyax Corp.	Binding peptides for carcinoembryonic antigen (CEA)
JP2010280569A (en) *	2007-09-25	2010-12-16	Jimro Co Ltd	Cxcl10 production inhibitor
CN102281884B (en) *	2008-12-02	2015-09-30	国家科学和技术研究委员会(Conicet)	Express the modification protozoon of at least two kinds of variable surface albumen (VSP), its vaccine and purification process, application and immunization method
EP2866821B1 (en)	2012-07-02	2018-11-14	Medizinische Universität Wien	Complement split product c4d for the treatment of inflammatory conditions
CN114502583A (en) *	2019-08-12	2022-05-13	杰特创新股份有限公司	Complement C2 binding proteins and uses thereof
WO2023143583A1 (en) *	2022-01-29	2023-08-03	Kira Pharmaceuticals (Suzhou) Ltd.	Anti-c2 antibodies and uses thereof

2000
- 2000-01-10 GB GBGB0000474.7A patent/GB0000474D0/en not_active Ceased
2001
- 2001-01-10 CA CA002397053A patent/CA2397053A1/en not_active Abandoned
- 2001-01-10 BR BR0107547-0A patent/BR0107547A/en not_active IP Right Cessation
- 2001-01-10 EP EP01900205A patent/EP1246840A2/en not_active Withdrawn
- 2001-01-10 MX MXPA02006817A patent/MXPA02006817A/en unknown
- 2001-01-10 AU AU2001223882A patent/AU2001223882A1/en not_active Abandoned
- 2001-01-10 JP JP2001551096A patent/JP2003519479A/en active Pending
- 2001-01-10 US US10/169,710 patent/US20030181362A1/en not_active Abandoned
- 2001-01-10 WO PCT/GB2001/000085 patent/WO2001051512A2/en not_active Application Discontinuation
2002
- 2002-07-09 ZA ZA200205485A patent/ZA200205485B/en unknown

Also Published As

Publication number	Publication date
JP2003519479A (en)	2003-06-24
MXPA02006817A (en)	2005-07-01
US20030181362A1 (en)	2003-09-25
BR0107547A (en)	2003-01-14
GB0000474D0 (en)	2000-03-01
CA2397053A1 (en)	2001-07-19
EP1246840A2 (en)	2002-10-09
ZA200205485B (en)	2003-12-31
WO2001051512A2 (en)	2001-07-19
WO2001051512A3 (en)	2002-03-14

Publication	Publication Date	Title
AU2001228665A1 (en)	2001-08-07	Toll-like receptor
AU2001262847A1 (en)	2001-12-11	Language-understanding
AU2001292739A1 (en)	2002-04-08	1-oxorapamycins
AU2000267458A1 (en)	2001-10-15	Hypercomputer
AU2001254546A1 (en)	2001-11-07	Aminopiperidines
AU2001239310A1 (en)	2001-10-03	Decahydro-isoquinolines
AU2001220246A1 (en)	2001-12-11	Neckphone
AU2001273032A1 (en)	2002-01-08	Cytokine receptor zcytor17
AU2001258349A1 (en)	2001-11-26	Bisacylguanidine
AU2001279754A1 (en)	2002-01-30	Indoloquinazolinones
AU2001285886A1 (en)	2002-03-22	2-guanidino-4-aryl-quinazoline
AU2001290931A1 (en)	2002-03-26	Ski-snowboard
AU2001265871A1 (en)	2001-11-07	Substituted sulfonylaminopyrimidines
AU2001258924A1 (en)	2001-11-26	Microsatellite-aflp
AU2001293852A1 (en)	2002-06-27	Sulfonylguanidine
AU2001254731A1 (en)	2001-10-23	Substituted phenyluracils
AU2001258255A1 (en)	2001-11-29	Substituted benzoylcyclohexenones
AU2001281921A1 (en)	2002-01-08	Bdellosomes
AU2001246864A1 (en)	2002-01-10	Hypotensors
AU2001291876A1 (en)	2002-06-20	Triazolo-epothilones
AU2001223882A1 (en)	2001-07-24	Receptor
AUPQ563400A0 (en)	2000-03-09	Novel receptor
AU1252102A (en)	2002-05-21	Receptor
AU2001226668A1 (en)	2001-09-12	Crankshaft-starter-generator
AU2001284173A1 (en)	2002-03-04	Calycins